Filed: 5/15/2024ACC: 0001013594-24-000479
📋 What this filing means
LION POINT CAPITAL, LP filed this quarterly 13F‑HR report disclosing 31 equity positions with a total reported market value of $178.95M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
31
Positions
$178.95M
Total AUM (reported)
17.20M
Total Shares
Allocation by class
COM$94.61M52.9%
RUSSELL 2000 ETF$52.05M29.1%
COM NEW$20.10M11.2%
S&P BIOTECH$4.74M2.7%
COM CL A$2.58M1.4%
COM PAR $.01$1.91M1.1%
SPONSORED ADR$1.39M0.8%
Portfolio Concentration
Top 3$139.93M78.2%
4–10$24.86M13.9%
11–25$13.59M7.6%
Rest$566.3K0.3%
Top 3 weight
78.2%
Top 10 weight
92.1%
Voting Authority Distribution
Total shares with voting rights: 17.20M
Sole
Full voting authority
17.20M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole31
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings31
Rows:
SEMTECH CORP
SOLEShares2.50M
TypeSH
Market value$68.73M
38.40%
Sole
2.50M
Shared
0.00
None
0.00
ISHARES TR
SOLEShares247.50K
TypeSH
Market value$52.05M
29.09%
Sole
247.50K
Shared
0.00
None
0.00
MARINUS PHARMACEUTICALS INC
SOLEShares2.12M
TypeSH
Market value$19.16M
10.71%
Sole
2.12M
Shared
0.00
None
0.00
ARDELYX INC
SOLEShares1.05M
TypeSH
Market value$7.64M
4.27%
Sole
1.05M
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares50K
TypeSH
Market value$4.74M
2.65%
Sole
50K
Shared
0.00
None
0.00
MILESTONE PHARMACEUTICALS IN
SOLEShares2.30M
TypeSH
Market value$4.12M
2.30%
Sole
2.30M
Shared
0.00
None
0.00
KINIKSA PHARMACEUTICALS LTD
SOLEShares130.69K
TypeSH
Market value$2.58M
1.44%
Sole
130.69K
Shared
0.00
None
0.00
GERON CORP
SOLEShares600K
TypeSH
Market value$1.98M
1.11%
Sole
600K
Shared
0.00
None
0.00
INSMED INC
SOLEShares70.33K
TypeSH
Market value$1.91M
1.07%
Sole
70.33K
Shared
0.00
None
0.00
FENNEC PHARMACEUTICALS INC
SOLEShares170K
TypeSH
Market value$1.89M
1.06%
Sole
170K
Shared
0.00
None
0.00
BURGERFI INTERNATIONAL INC
SOLEShares2.75M
TypeSH
Market value$1.59M
0.89%
Sole
2.75M
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares65K
TypeSH
Market value$1.55M
0.86%
Sole
65K
Shared
0.00
None
0.00
AVADEL PHARMACEUTICALS PLC
SOLEShares82.50K
TypeSH
Market value$1.39M
0.78%
Sole
82.50K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares45K
TypeSH
Market value$1.13M
0.63%
Sole
45K
Shared
0.00
None
0.00
BLUEBIRD BIO INC
SOLEShares848.26K
TypeSH
Market value$1.09M
0.61%
Sole
848.26K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares7.50K
TypeSH
Market value$1.03M
0.58%
Sole
7.50K
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares32K
TypeSH
Market value$939.5K
0.53%
Sole
32K
Shared
0.00
None
0.00
ENPHYS ACQUISITION CORP
SOLEShares78.13K
TypeSH
Market value$845.3K
0.47%
Sole
78.13K
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares60K
TypeSH
Market value$774.6K
0.43%
Sole
60K
Shared
0.00
None
0.00
HUMACYTE INC
SOLEShares235K
TypeSH
Market value$730.9K
0.41%
Sole
235K
Shared
0.00
None
0.00
REGENXBIO INC
SOLEShares32.50K
TypeSH
Market value$684.8K
0.38%
Sole
32.50K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares1M
TypePRN
Market value$629.5K
0.35%
Sole
1M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares78K
TypeSH
Market value$601.4K
0.34%
Sole
78K
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares42.50K
TypeSH
Market value$347.2K
0.19%
Sole
42.50K
Shared
0.00
None
0.00
SERES THERAPEUTICS INC
SOLEShares340.76K
TypeSH
Market value$263.8K
0.15%
Sole
340.76K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SEMTECH CORPSOLE | COM | 2.50M | SH | $68.73M 38.40% | 2.50M | 0.00 | 0.00 |
ISHARES TRSOLE | RUSSELL 2000 ETF | 247.50K | SH | $52.05M 29.09% | 247.50K | 0.00 | 0.00 |
MARINUS PHARMACEUTICALS INCSOLE | COM NEW | 2.12M | SH | $19.16M 10.71% | 2.12M | 0.00 | 0.00 |
ARDELYX INCSOLE | COM | 1.05M | SH | $7.64M 4.27% | 1.05M | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P BIOTECH | 50K | SH | $4.74M 2.65% | 50K | 0.00 | 0.00 |
MILESTONE PHARMACEUTICALS INSOLE | COM | 2.30M | SH | $4.12M 2.30% | 2.30M | 0.00 | 0.00 |
KINIKSA PHARMACEUTICALS LTDSOLE | COM CL A | 130.69K | SH | $2.58M 1.44% | 130.69K | 0.00 | 0.00 |
GERON CORPSOLE | COM | 600K | SH | $1.98M 1.11% | 600K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 70.33K | SH | $1.91M 1.07% | 70.33K | 0.00 | 0.00 |
FENNEC PHARMACEUTICALS INCSOLE | COM | 170K | SH | $1.89M 1.06% | 170K | 0.00 | 0.00 |
BURGERFI INTERNATIONAL INCSOLE | COM | 2.75M | SH | $1.59M 0.89% | 2.75M | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 65K | SH | $1.55M 0.86% | 65K | 0.00 | 0.00 |
AVADEL PHARMACEUTICALS PLCSOLE | SPONSORED ADR | 82.50K | SH | $1.39M 0.78% | 82.50K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 45K | SH | $1.13M 0.63% | 45K | 0.00 | 0.00 |
BLUEBIRD BIO INCSOLE | COM | 848.26K | SH | $1.09M 0.61% | 848.26K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 7.50K | SH | $1.03M 0.58% | 7.50K | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM NEW | 32K | SH | $939.5K 0.53% | 32K | 0.00 | 0.00 |
ENPHYS ACQUISITION CORPSOLE | CL A ORD SHS | 78.13K | SH | $845.3K 0.47% | 78.13K | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 60K | SH | $774.6K 0.43% | 60K | 0.00 | 0.00 |
HUMACYTE INCSOLE | COM | 235K | SH | $730.9K 0.41% | 235K | 0.00 | 0.00 |
REGENXBIO INCSOLE | COM | 32.50K | SH | $684.8K 0.38% | 32.50K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | NOTE 2.250% 3/0 | 1M | PRN | $629.5K 0.35% | 1M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 78K | SH | $601.4K 0.34% | 78K | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 42.50K | SH | $347.2K 0.19% | 42.50K | 0.00 | 0.00 |
SERES THERAPEUTICS INCSOLE | COM | 340.76K | SH | $263.8K 0.15% | 340.76K | 0.00 | 0.00 |
Page 1 of 2